Cadrenal Therapeutics Inc

NASDAQ:CVKD

12.98

+0.54 (+4.34%)

4:33:48 PM EDT: $12.34 -0.64 (-4.93%)

Cadrenal Therapeutics Inc Stock, NASDAQ:CVKD

822 A1A North, Suite 306, Ponte Vedra Beach, Florida 32082

United States of America

Phone: +1.904.300.0701

Number of Employees: 4

http://www.cadrenal.com

Description

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang Pham and Matthew Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.